Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue
Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (...
Saved in:
Published in | International neurourology journal Vol. 20; no. 2; pp. 122 - 130 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Continence Society
01.06.2016
대한배뇨장애요실금학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2093-6931 2093-4777 2093-6931 |
DOI | 10.5213/inj.1632552.276 |
Cover
Abstract | Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue.
A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons.
Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9).
These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections. |
---|---|
AbstractList | Purpose: Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. Methods: A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons. Results: Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9). Conclusions: These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections. Purpose: Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. Methods: A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons. Results: Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9). Conclusions: These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections. KCI Citation Count: 12 Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue.PURPOSEPreviously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue.A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons.METHODSA total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons.Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9).RESULTSReal-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9).These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections.CONCLUSIONSThese results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections. Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the expression of two herpes virus-encoded miRNAs in prostate tissue. A total of 175 tissue samples from noncancerous benign prostatic hyperplasia (BPH), 248 tissue samples from patients with CaP and BPH, and 50 samples from noncancerous surrounding tissues from these same patients were analyzed for the expression of two herpes virus-encoded miRNAs by real-time polymerase chain reaction (PCR) and immunocytochemistry using nanoparticles as molecular beacons. Real-time reverse transcription-PCR results revealed significantly higher expression of hsv1-miR-H18 and hsv2-miRH9- 5p in surrounding noncancerous and CaP tissues than that in BPH tissue (each comparison, P<0.001). Of note, these miRNA were expressed equivalently in the CaP tissues and surrounding noncancerous tissues. Moreover, immunocytochemistry clearly demonstrated a significant enrichment of both hsv1-miR-H18 and hsv2-miR-H9 beacon-labeled cells in CaP and surrounding noncancerous tissue compared to that in BPH tissue (each comparison, P<0.05 for hsv1-miR-H18 and hsv2- miR-H9). These results suggest that increased expression of hsv1-miR-H18 and hsv2-miR-H95p might be associated with tumorigenesis in the prostate. Further studies will be required to elucidate the role of these miRNAs with respect to CaP and herpes viral infections. |
Author | Kim, Wun-Jae Ha, Yun-Sok Kim, Nam-Hyung Kim, Won Tae Kwon, Tae Gyun Choi, Young-Ki Lee, Ok-Jun Kim, Jung Min Kim, Tae-Hwan Kim, Dongho Kim, Sang Tae Cha, Eun-Jong Kim, Ye-Hwan Choi, Yung-Hyun Kim, Isaac Yi Yun, Seok Joong Kim, Jayoung Kang, Ho Won Jeong, Pildu Suh, Sang Heon Yan, Chunri Kim, Seon-Young Shinn, Helen Ki Ryu, Dong Hee Moon, Sung-Kwon Cha, Hee-Jae Kim, Seon-Kyu |
Author_xml | – sequence: 1 givenname: Seok Joong surname: Yun fullname: Yun, Seok Joong – sequence: 2 givenname: Pildu surname: Jeong fullname: Jeong, Pildu – sequence: 3 givenname: Ho Won surname: Kang fullname: Kang, Ho Won – sequence: 4 givenname: Helen Ki surname: Shinn fullname: Shinn, Helen Ki – sequence: 5 givenname: Ye-Hwan surname: Kim fullname: Kim, Ye-Hwan – sequence: 6 givenname: Chunri surname: Yan fullname: Yan, Chunri – sequence: 7 givenname: Young-Ki surname: Choi fullname: Choi, Young-Ki – sequence: 8 givenname: Dongho surname: Kim fullname: Kim, Dongho – sequence: 9 givenname: Dong Hee surname: Ryu fullname: Ryu, Dong Hee – sequence: 10 givenname: Yun-Sok surname: Ha fullname: Ha, Yun-Sok – sequence: 11 givenname: Tae-Hwan surname: Kim fullname: Kim, Tae-Hwan – sequence: 12 givenname: Tae Gyun surname: Kwon fullname: Kwon, Tae Gyun – sequence: 13 givenname: Jung Min surname: Kim fullname: Kim, Jung Min – sequence: 14 givenname: Sang Heon surname: Suh fullname: Suh, Sang Heon – sequence: 15 givenname: Seon-Kyu surname: Kim fullname: Kim, Seon-Kyu – sequence: 16 givenname: Seon-Young surname: Kim fullname: Kim, Seon-Young – sequence: 17 givenname: Sang Tae surname: Kim fullname: Kim, Sang Tae – sequence: 18 givenname: Won Tae surname: Kim fullname: Kim, Won Tae – sequence: 19 givenname: Ok-Jun surname: Lee fullname: Lee, Ok-Jun – sequence: 20 givenname: Sung-Kwon surname: Moon fullname: Moon, Sung-Kwon – sequence: 21 givenname: Nam-Hyung surname: Kim fullname: Kim, Nam-Hyung – sequence: 22 givenname: Isaac Yi surname: Kim fullname: Kim, Isaac Yi – sequence: 23 givenname: Jayoung surname: Kim fullname: Kim, Jayoung – sequence: 24 givenname: Hee-Jae surname: Cha fullname: Cha, Hee-Jae – sequence: 25 givenname: Yung-Hyun surname: Choi fullname: Choi, Yung-Hyun – sequence: 26 givenname: Eun-Jong surname: Cha fullname: Cha, Eun-Jong – sequence: 27 givenname: Wun-Jae surname: Kim fullname: Kim, Wun-Jae |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27377944$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002122042$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1Uk1v0zAYttAQG2VnbihHOKTzZ-xckLao0EqTQFPhajmO3bpL7WCnE_tH_Ey8toMNCV9e6_XzYft9XoMTH7wB4C2CU4YRuXB-M0UVwYzhKebVC3CGYU3Kqibo5Mn-FJyntIF5Ucoh46_AKeaE85rSM_Br4XU0KpmumP0coknJBV8EW8xNHEwqvru4S-XM69BlyDrdoXLrbso5EoXy-wY-NOqSDYXzRaO8NrFsgh-V886viq8xpFGNpli6lHamaMJ2UDGrjaFYrtX4wLoy3q38X-j8fsj-vUpOHWlvwEur-mTOj3UCvn2aLZt5ef3l86K5vC41rclY1gIpYZiGHVLW1jXWrIM1JBwz1Fa2RZYzi4iGFGLBta0MJUIjKzomWkgEmYAPB10frbzVTgbl9nUV5G2UlzfLhUQQVUzwjF0csF1QGzlEt1Xxfk_YN0JcSRVHp3sjsWi1gZgoriqKjBIVsoRCJBirO9uSrPXxoDXs2q3ptPFjVP0z0ecn3q3zne5kfjauKM0C748CMfzYmTTKrUva9L3yJuySRAJiygnLsZiAd0-9_pg8xiID2AGg80BSNFZql-eSo5GtXZ8_QD4kUOYEymMCM7nKvIt_eI_S_2P8BrAZ3ac |
CitedBy_id | crossref_primary_10_1016_j_prnil_2021_11_003 crossref_primary_10_1016_j_exger_2021_111304 crossref_primary_10_1007_s12223_020_00780_x crossref_primary_10_1002_rmv_2081 crossref_primary_10_1177_1756287219857271 crossref_primary_10_1128_jvi_00349_22 crossref_primary_10_1016_j_euf_2018_01_008 crossref_primary_10_4111_icu_20210493 crossref_primary_10_1016_j_jneuroim_2017_03_002 crossref_primary_10_5213_inj_1836262_131 crossref_primary_10_1186_s12610_023_00193_z |
Cites_doi | 10.1038/nrc2090 10.3322/caac.20073 10.1038/nprot.2006.162 10.1186/1471-2105-11-249 10.1126/science.1096781 10.3346/jkms.2009.24.6.995 10.5213/inj.2015.19.2.74 10.1002/path.2936 10.1016/j.vaccine.2008.05.064 10.1016/S1097-2765(01)00227-1 10.1016/j.canep.2014.06.002 10.1016/0090-4295(84)90118-3 10.1073/pnas.1318157111 10.1002/smll.200500360 10.1158/1055-9965.EPI-08-1167 10.1038/nmeth746 10.2217/fon.10.95 10.1158/1055-9965.EPI-07-0134 |
ContentType | Journal Article |
Copyright | Copyright © 2016 Korean Continence Society 2016 |
Copyright_xml | – notice: Copyright © 2016 Korean Continence Society 2016 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
DOI | 10.5213/inj.1632552.276 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2093-6931 |
EndPage | 130 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1016587 oai_doaj_org_article_28bce023a7a641ea861f34018559dfb3 PMC4932644 27377944 10_5213_inj_1632552_276 |
Genre | Journal Article |
GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL AAKDD AAYXX ABDBF ACUHS ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK E3Z EBD EF. F5P GROUPED_DOAJ HYE OK1 RPM NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c493t-981a8e5c0d1aff992c5d09037251b6fb1f75f13c040287cf6e438c1f8d58b0383 |
IEDL.DBID | DOA |
ISSN | 2093-6931 2093-4777 |
IngestDate | Tue Nov 21 21:43:34 EST 2023 Wed Aug 27 01:31:13 EDT 2025 Thu Aug 21 14:05:06 EDT 2025 Fri Jul 11 07:52:59 EDT 2025 Thu Jan 02 22:25:12 EST 2025 Tue Jul 01 00:28:41 EDT 2025 Thu Apr 24 23:06:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Prostate Neoplasms Herpesviridae MicroRNAs Prostate Hyperplasia |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c493t-981a8e5c0d1aff992c5d09037251b6fb1f75f13c040287cf6e438c1f8d58b0383 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Geun Ho Park and Helen Ki Shinn contributed equally to this study as co-first authors. G704-001728.2016.20.2.007 |
ORCID | 0000-0002-1967-5281 0000-0001-6319-0217 0000-0002-1030-7730 0000-0002-4390-0952 0000-0003-4560-8880 0000-0002-1409-3311 0000-0002-1454-3124 0000-0002-4176-5187 0000-0001-6088-298X 0000-0002-8060-8926 0000-0003-3732-9814 0000-0001-7737-4746 0000-0002-8164-4427 0000-0002-5602-5376 0000-0002-1894-9869 0000-0002-8676-7119 0000-0002-6963-2685 |
OpenAccessLink | https://doaj.org/article/28bce023a7a641ea861f34018559dfb3 |
PMID | 27377944 |
PQID | 1802473509 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1016587 doaj_primary_oai_doaj_org_article_28bce023a7a641ea861f34018559dfb3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4932644 proquest_miscellaneous_1802473509 pubmed_primary_27377944 crossref_citationtrail_10_5213_inj_1632552_276 crossref_primary_10_5213_inj_1632552_276 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-06-01 |
PublicationDateYYYYMMDD | 2016-06-01 |
PublicationDate_xml | – month: 06 year: 2016 text: 2016-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | International neurourology journal |
PublicationTitleAlternate | Int Neurourol J |
PublicationYear | 2016 |
Publisher | Korean Continence Society 대한배뇨장애요실금학회 |
Publisher_xml | – name: Korean Continence Society – name: 대한배뇨장애요실금학회 |
References | ref13 ref12 ref15 ref14 ref11 ref10 Ge (ref20) 2013 ref2 ref1 ref17 ref16 ref19 ref18 ref8 ref7 ref9 ref3 ref6 ref5 Sfanos (ref4) 2013 20465802 - BMC Bioinformatics. 2010 May 13;11:249 17193022 - Small. 2006 Feb;2(2):209-15 28043100 - Int Neurourol J. 2016 Dec;20(4):374 19949651 - J Korean Med Sci. 2009 Dec;24(6):995-1003 21744342 - J Pathol. 2011 Sep;225(1):19-28 15782219 - Nat Methods. 2005 Apr;2(4):269-76 26126436 - Int Neurourol J. 2015 Jun;19(2):74-84 18847553 - Vaccine. 2008 Aug 19;26 Suppl 10:K1-16 24367088 - Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E592-600 24648964 - Biomed Rep. 2013 May;1(3):433-439 19755645 - Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2665-71 17406398 - Nat Protoc. 2006;1(3):1160-4 15118162 - Science. 2004 Apr 30;304(5671):734-6 17384581 - Nat Rev Cancer. 2007 Apr;7(4):256-69 24986642 - Cancer Epidemiol. 2014 Aug;38(4):329-38 20610543 - CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300 20799875 - Future Oncol. 2010 Aug;6(8):1289-311 11336706 - Mol Cell. 2001 Apr;7(4):833-43 25110720 - Am J Clin Exp Urol. 2013 Dec 25;1(1):3-11 17684131 - Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1573-80 6209848 - Urology. 1984 Dec;24(6):623-5 |
References_xml | – ident: ref3 doi: 10.1038/nrc2090 – ident: ref1 doi: 10.3322/caac.20073 – ident: ref12 doi: 10.1038/nprot.2006.162 – ident: ref8 doi: 10.1186/1471-2105-11-249 – ident: ref14 doi: 10.1126/science.1096781 – start-page: 3 volume-title: Infections and inflammation in prostate cancer year: 2013 ident: ref4 – ident: ref2 doi: 10.3346/jkms.2009.24.6.995 – ident: ref10 doi: 10.5213/inj.2015.19.2.74 – ident: ref13 doi: 10.1002/path.2936 – ident: ref15 doi: 10.1016/j.vaccine.2008.05.064 – ident: ref9 doi: 10.1016/S1097-2765(01)00227-1 – ident: ref6 doi: 10.1016/j.canep.2014.06.002 – ident: ref17 doi: 10.1016/0090-4295(84)90118-3 – start-page: 433 volume-title: Herpes simplex virus type 2 or human herpesvirus 8 infection and prostate cancer risk: a meta-analysis year: 2013 ident: ref20 – ident: ref5 doi: 10.1073/pnas.1318157111 – ident: ref11 doi: 10.1002/smll.200500360 – ident: ref18 doi: 10.1158/1055-9965.EPI-08-1167 – ident: ref7 doi: 10.1038/nmeth746 – ident: ref16 doi: 10.2217/fon.10.95 – ident: ref19 doi: 10.1158/1055-9965.EPI-07-0134 – reference: 15118162 - Science. 2004 Apr 30;304(5671):734-6 – reference: 28043100 - Int Neurourol J. 2016 Dec;20(4):374 – reference: 17406398 - Nat Protoc. 2006;1(3):1160-4 – reference: 17384581 - Nat Rev Cancer. 2007 Apr;7(4):256-69 – reference: 25110720 - Am J Clin Exp Urol. 2013 Dec 25;1(1):3-11 – reference: 26126436 - Int Neurourol J. 2015 Jun;19(2):74-84 – reference: 19949651 - J Korean Med Sci. 2009 Dec;24(6):995-1003 – reference: 24986642 - Cancer Epidemiol. 2014 Aug;38(4):329-38 – reference: 20465802 - BMC Bioinformatics. 2010 May 13;11:249 – reference: 6209848 - Urology. 1984 Dec;24(6):623-5 – reference: 11336706 - Mol Cell. 2001 Apr;7(4):833-43 – reference: 24648964 - Biomed Rep. 2013 May;1(3):433-439 – reference: 18847553 - Vaccine. 2008 Aug 19;26 Suppl 10:K1-16 – reference: 19755645 - Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2665-71 – reference: 17684131 - Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1573-80 – reference: 15782219 - Nat Methods. 2005 Apr;2(4):269-76 – reference: 21744342 - J Pathol. 2011 Sep;225(1):19-28 – reference: 17193022 - Small. 2006 Feb;2(2):209-15 – reference: 20799875 - Future Oncol. 2010 Aug;6(8):1289-311 – reference: 24367088 - Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E592-600 – reference: 20610543 - CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300 |
SSID | ssj0000447057 |
Score | 2.0961514 |
Snippet | Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we investigated the... Purpose: Previously, we reported the presence of virus-encoded microRNAs (miRNAs) in the urine of prostate cancer (CaP) patients. In this study, we... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 122 |
SubjectTerms | Herpesviridae MicroRNAs Original Prostate Hyperplasia Prostate Neoplasms 비뇨기과학 |
Title | Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27377944 https://www.proquest.com/docview/1802473509 https://pubmed.ncbi.nlm.nih.gov/PMC4932644 https://doaj.org/article/28bce023a7a641ea861f34018559dfb3 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002122042 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | International Neurourology Journal, 2016, 20(2), , pp.122-130 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHhAXxPIMLxnEgYt348aJnSNbdVWQFiHURXuzHD-20YJbpe2Kn8TPZMbJlhaBuHCK5NiRkxnPfOOMvyHkDe6tgR_3zEnnmfAlZ8YEx0LpmkLg6vJ4OPnsYzU9Fx8uyoudUl-YE9bTA_cf7nikGuvBsRhpKsG9URUPBQQFCqCwC03i-czrfCeYSjZYCJknmk-4WTAhpex5fcBbFcdtBAtRFYCmR0cjZBvZcUmJuR8cTezCn0Dn77mTO87o9B65O6BI-q6f_SG55eN9cvts-E_-gPyAZY_Z5t7Ryfch1TXSRaBT3y39in5pu82KTSIeaHd0vrrm7Fv7mU25oiamhlHfULNySdtIx6gcHUMuq76kBP2Ex0UAqNJZEh0dD8nsdL2gs7lZ46gTH9vL-KvrFILebpkObg7DHpLz08lsPGVDTQZmRV2sWa24Ub60ueMmhLoe2dLhVo8EnNRUoeFBloEXFmwDxGI2VF4UyvKgXKmaHMLhR-QgLqJ_QmiwYKUdd0IJJ7z0tRfCFvBUaeAZdZWRoxuxaDsQlmPdjK8aAheUowY56kGOGuSYkbfbAcueq-PvXU9QzttuSLKdGkD19KB6-l-ql5HXoCX6yrZpPF4vF_qq0xCKvE-5c6WSGXl1o0QaVi7-jjHRLzYrjdx7WPg5rzPyuFeq7XwAVEqwlCIjck_d9ia8fye288QOLhCRC_H0f7zhM3IHAGLVp8Y9JwfrbuNfAAhbNy_TevsJecAttw |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Expression+of+Herpes+Virus-Encoded+hsv1-miR-H18+and+hsv2-miR-H9-5p+in+Cancer-Containing+Prostate+Tissue+Compared+to+That+in+Benign+Prostate+Hyperplasia+Tissue&rft.jtitle=International+neurourology+journal&rft.au=Yun%2C+Seok+Joong&rft.au=Jeong%2C+Pildu&rft.au=Kang%2C+Ho+Won&rft.au=Shinn%2C+Helen+Ki&rft.date=2016-06-01&rft.pub=Korean+Continence+Society&rft.issn=2093-4777&rft.eissn=2093-6931&rft.volume=20&rft.issue=2&rft.spage=122&rft.epage=130&rft_id=info:doi/10.5213%2Finj.1632552.276&rft_id=info%3Apmid%2F27377944&rft.externalDocID=PMC4932644 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-6931&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-6931&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-6931&client=summon |